Non-invasive prenatal diagnostic test for Down's Syndrome

Mundy L, Hiller JE
Record ID 32012000229
Authors' recomendations: The isolation of foetal RNA and DNA from maternal blood appears to be feasible for the non-invasive diagnosis of Down's Syndrome. Both tests need to be optimised for their routine use in prenatal testing and large-scale studies should be conducted. Therefore HealthPACT recommended that this technology be monitored for further information in 12-months time.
Project Status: Completed
Year Published: 2008
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Down Syndrome
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
Contact Email:
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.